Clinical Trial Update: Study of Danggui Buxue Decoction in Preventing Neutropenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Danggui Buxue Decoction for preventing Grade 3/4 neutropenia and febrile neutropenia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Neutropenia

Drugs mentioned

• Danggui Buxue Decoction

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Grade 3/4 Neutropenia, Febrile Neutropenia | Phase 2 | Status: COMPLETED